COVID Prevention Counseling and Text Messaging for COVID-19
Trial Summary
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the idea that COVID Prevention Counseling and Text Messaging for COVID-19 is an effective treatment?
The available research does not provide specific data on the effectiveness of COVID Prevention Counseling and Text Messaging for COVID-19. The articles focus on other programs and treatments, such as critical care pathways for different conditions and a Community Paramedic Program for transitioning patients from hospital to home. Without direct evidence from these studies, we cannot conclude the effectiveness of the COVID Prevention Program.12345
What safety data exists for the COVID Prevention Counseling and Text Messaging for COVID-19 treatment?
The provided research does not contain specific safety data for the COVID Prevention Counseling and Text Messaging for COVID-19 treatment or its other names like COVID Prevention Program (CPP). The research primarily focuses on COVID-19 vaccine safety and adverse events following immunization, not on counseling or text messaging interventions.678910
Is the COVID Prevention Program (CPP) a promising treatment for COVID-19?
How is the COVID Prevention Program (CPP) treatment different from other COVID-19 treatments?
The COVID Prevention Program (CPP) is unique because it combines counseling and text messaging to support COVID-19 prevention, focusing on remote and accessible communication methods to help people manage their health and well-being during the pandemic. This approach is different from traditional treatments that often involve medication or in-person care, as it leverages technology to provide support and information.811121314
What is the purpose of this trial?
This study will examine the effectiveness of a 6-week behavioral intervention for patients who are recently diagnosed with COVID-19. Patients and their households will be randomized to one of two groups (Standard of Care vs. Enhanced Standard of Care). Patients in the Standard-of-Care group will receive established clinical care and follow-up. Patients in the Enhanced Standard-of-Care group will receive standard-of-care plus tailored, real-time text messaging and virtual counseling delivered by promotores/as. The investigators hypothesize that households in the Enhanced Standard-of-Care group will have fewer (any new) household COVID-19 infectivity rates compared to households in the standard-of-care group post-intervention.
Research Team
Noe C Crespo, M.P.H, Ph.D.
Principal Investigator
San Diego State University Research Foundation
Eligibility Criteria
This trial is for adult patients over 18 years old who have tested positive for COVID-19 and are clients of a federally qualified health center. It's not suitable for those planning to move out of state within a year, individuals with cognitive impairments like schizophrenia or Down syndrome, or people without stable housing.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 6-week behavioral intervention with either standard-of-care or enhanced standard-of-care, including tailored phone/mobile counseling and weekly text messaging
Follow-up
Participants are monitored for safety and effectiveness after treatment, with primary and secondary outcomes measured at multiple timepoints
Treatment Details
Interventions
- COVID Prevention Program (CPP)
Find a Clinic Near You
Who Is Running the Clinical Trial?
San Diego State University
Lead Sponsor
Family Health Centers of San Diego
Collaborator